SSRI Given for Post-ACS Depression May Cut Cardiac Event Risk SSRI Given for Post-ACS Depression May Cut Cardiac Event Risk

The apparent cardioprotection in such patients put on the selective serotonin reuptake inhibitor escitalopram lasted 8 years in a single-center but randomized trial.Medscape Medical News
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Cardiology News Source Type: news